CR
Cardiol Therapeutics Inc.
CRDL · NASDAQ
$1.71 -2.28% (-$0.04)
1M -11.86%
Market Cap $282.1M
P/E Ratio -
Div. Yield -
ROE 193.63%
Bulios Fair Price
$1.55
9.4% downside
Trenutna cena
$1.71
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRDL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 11.74x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 22.57%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 162.44%
ROE 193.63%
ROA 124.84%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 5.55x
Int. coverage N/A
Stability
67 /100
Stable Beta 0.52x
EPS volatility 20.06%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRDL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David G. Elsley
Employees
18
Headquarters
Oakville
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report